Shanghai - Delayed Quote CNY

HLA (600398.SS)

7.23

-0.01

(-0.14%)

At close: 3:00:01 PM GMT+8

Trump-Musk fight reveals fragility of relationship between Silicon Valley and White House

The falling out between President Trump and Elon Musk is just the latest reminder that the relationship between the new White House and the titans of technology has turned out to be complicated.

Yahoo Finance 17 hours ago

MSFT

AMZN

NVDA
Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

Supernus Pharmaceuticals agreed Monday to buy beleaguered biotech Sage Therapeutics in a deal worth up to $561 million.

Investor's Business Daily 45 minutes ago

SAGE

SUPN

BIIB
Sarepta down analysts flag risks after second Elevidys-linked death

Investing.com -- BMO Capital and Piper Sandler downgraded Sarepta Therapeutics (NASDAQ:SRPT) after the company reported a second death linked to its gene therapy Elevidys in a non-ambulatory Duchenne muscular dystrophy (DMD) patient.Shares of the company are down around 35% in premarket trading.

Investing.com 46 minutes ago

SRPT
This Stock Soars 43% As Trump Urges FCC To Settle Dispute

EchoStar stock soars on reports that President Trump urged the company, FCC to reach a deal regarding spectrum licenses.

Investor's Business Daily 1 hour ago

SATS
Crypto group Tron to go public in US via reverse-merger with SRM

Hong Kong-based crypto entrepreneur Justin Sun's blockchain group Tron will go public in the United States in a reverse merger with SRM Entertainment, the companies said on Monday.

Reuters 1 hour ago

SRM
Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

Palantir is benefiting from AI, but its shares sport a rich valuation today. Nvidia is dominating the AI processor market, and demand hasn't slowed. Microsoft made early moves into AI that are already paying off.

Motley Fool 1 hour ago

PLTR

NVDA

MSFT
Sonim Technologies Confirms Receipt of Non-Binding Unsolicited Indication of Interest

San Diego, California--(Newsfile Corp. - June 16, 2025) - The Special Committee of the Board of Directors (the "Special Committee") of Sonim Technologies, Inc. (NASDAQ: SONM), formed to oversee the Company's ongoing strategic alternatives process, today confirmed receipt of an unsolicited indication of interest issued by DOOGEE on June 9, 2025 in the form of a press release, to acquire all outstanding shares of Sonim for $3.60 per share in cash. The Special Committee ...

Newsfile 1 hour ago

SONM
Palantir Price Target Raised to $155 on 'Explosive' AI Potential

Loop Capital Lifts Palantir Target to $155 After CFO Meeting

GuruFocus.com 1 hour ago

PLTR
Roku stock surges on Amazon Ads partnership

Investing.com -- Roku shares surged 9.8% premarket on Monday after the company announced an exclusive partnership with Amazon (NASDAQ:AMZN) Ads, creating what the firms describe as the “largest authenticated Connected TV (CTV) footprint in the U.S.”

Investing.com 1 hour ago

ROKU

AMZN

DIS
Tesla (TSLA) Raises U.S. Prices on Upgraded Model S and X by $5,000

EV maker hikes prices after rolling out updates to premium vehicles

GuruFocus.com 1 hour ago

TSLA
5 Things to Know Before the Stock Market Opens

News of the day for June 16, 2025

Investopedia 1 hour ago

SRPT

MSFT

SATS
Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland

Non-dilutive funding package expected to be sufficient to enable the Tanbreez Project to complete pre-production activities and commence miningNEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that it has received a Letter of Interest from the Export-Import Bank of the United States (EXIM), for a total non-dilutive funding package of $120 million. This funding pac

GlobeNewswire 1 hour ago

CRML

CRMLW
Reddit unveils AI-driven ad tools to help brands tap into user discussions

The company said its AI-driven tool, "Reddit Insights", would provide real-time insights to marketers for planning campaigns by identifying trends on the platform and testing campaign ideas. It will also provide a feature called "Conversation Summary Add-ons", allowing brands to integrate "positive" user comments directly under the ads to show what they think about the ad subject. Platforms such as Reddit, Snap and Pinterest are leaning on AI-driven ad targeting tools to attract marketers in a fiercely competitive ad market amid economic uncertainties.

Reuters 2 hours ago

RDDT
Sarepta and Roche halt DMD gene therapy’s use after second death

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Pharmaceutical Technology 2 hours ago

ROG.SW

SRPT
Palantir 'Golden Dome' Upside Eyed Amid High Valuation. Is Palantir Stock A Buy Or Sell?

Palantir stock bulls tout the software maker's artificial intelligence strategy and potential to win more U.S. government contracts.

Investor's Business Daily 2 hours ago

PLTR
Sage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.

Supernus Pharmaceuticals signed a definitive agreement to acquire fellow biopharmaceutical company Sage Therapeutics for $8.50 a share in a deal worth an initial $561 million. The terms also includes one non-tradable contingent value right ( CVR ) payable upon achieving certain sales goals, which could bring Sage shareholders an additional $3.50 a share and $234 million by the end of 2030. The main draw of the deal for Supernus is Sage’s drug Zurzuvae, the first and only oral medication approved by the Food and Drug Administration for treatment of postpartum depression.

Barrons.com 2 hours ago

SAGE

SUPN
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base.Strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® (zuranolone), and a novel CNS discovery platform.Expected to be significantly accretive in 2026 with potential cost synergies of up to $200 million on an annual basis.Upfront cash payment of $8.50 per share, plus one non-tradable contingent value right (C

GlobeNewswire 2 hours ago

SAGE

SUPN
Market Chatter: EchoStar's Spectrum Crisis Draws White House Intervention; Shares Rise Pre-Bell

EchoStar (SATS) shares rose more than 48% in Monday's premarket activity as President Donald Trump s

PREMIUM
MT Newswires 3 hours ago

SATS
Electric Vehicles Update - Luxury Auto Sector Accelerates With Eco-Friendly Innovations

The luxury electric vehicles (EV) market is on a rapid growth trajectory, with forecasts indicating a surge in market value from USD 202.3 billion in 2025 to USD 1.04 trillion by 2034, achieving a compound annual growth rate (CAGR) of 20.0%. This expansion is driven by a fusion of environmental consciousness and advanced technology, as premium automakers like Mercedes-Benz, BMW, and Tesla lead the charge in offering high-performance, eco-friendly models. Key markets in China, the U.S., and...

Simply Wall St. 3 hours ago

TSLA

BYDDF

BYDDY
These Stocks Are Moving the Most Today: Sarepta, Tesla, U.S. Steel, Victoria’s Secret, Lennar, and More

Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of the death of a second patient from acute liver failure.

Barrons.com 3 hours ago

LEN-B

X

TSLA

Performance Overview

Return	600398.SS	SSE Composite Index (000001.SS)
YTD	-3.60%	+1.10%
1-Year	-20.27%	+11.74%
3-Year	+79.84%	+3.15%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

HLA (600398.SS)

Related News

Trump-Musk fight reveals fragility of relationship between Silicon Valley and White House

Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

Sarepta down analysts flag risks after second Elevidys-linked death

This Stock Soars 43% As Trump Urges FCC To Settle Dispute

Crypto group Tron to go public in US via reverse-merger with SRM

Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

Sonim Technologies Confirms Receipt of Non-Binding Unsolicited Indication of Interest

Palantir Price Target Raised to $155 on 'Explosive' AI Potential

Roku stock surges on Amazon Ads partnership

Tesla (TSLA) Raises U.S. Prices on Upgraded Model S and X by $5,000

5 Things to Know Before the Stock Market Opens

Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland

Reddit unveils AI-driven ad tools to help brands tap into user discussions

Sarepta and Roche halt DMD gene therapy’s use after second death

Palantir 'Golden Dome' Upside Eyed Amid High Valuation. Is Palantir Stock A Buy Or Sell?

Sage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

Market Chatter: EchoStar's Spectrum Crisis Draws White House Intervention; Shares Rise Pre-Bell

Electric Vehicles Update - Luxury Auto Sector Accelerates With Eco-Friendly Innovations

These Stocks Are Moving the Most Today: Sarepta, Tesla, U.S. Steel, Victoria’s Secret, Lennar, and More

Performance Overview